R&D Strong solutions for increasing dermatology research diversi... As a woman of colour, I am very careful about the skin care products I use. I must be.
R&D Worrying signs for trial diversity require broad industry ac... A recent report found that diversity in clinical trials has dropped.
Views & Analysis Inclusive research and tackling health inequalities Health inequalities are a long-term condition and inclusive research is the only disease modifying therapy in the pipeline – but how can the community drive practical change?
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
